Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPOPROSTENOL vs EPTIFIBATIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPOPROSTENOL vs EPTIFIBATIDE: Safety Overview

Metric EPOPROSTENOL EPTIFIBATIDE
Total FAERS Reports 13,322 462
Deaths Reported 2,713 57
Death Rate 20.4% 12.3%
Hospitalizations 8,838 143
Average Patient Age 49.9 yrs 57.2 yrs
% Female Patients 78.1% 30.9%
FDA Approval Date Apr 23, 2008 Apr 18, 2017
Manufacturer Mylan Institutional LLC Slate Run Pharmaceuticals, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued